从普拉格雷转换为氯吡格雷：在未知水域中航行。 - Suppr

Suppr

超能文献

Switching from prasugrel to clopidogrel: navigating in unknown waters.

作者信息

Angiolillo Dominick J, Rollini Fabiana

出版信息

JACC Cardiovasc Interv. 2013 Feb;6(2):166-8. doi: 10.1016/j.jcin.2012.12.001.

DOI:10.1016/j.jcin.2012.12.001

PMID:23428008

Abstract

摘要

相似文献

Switching from prasugrel to clopidogrel: navigating in unknown waters.

JACC Cardiovasc Interv. 2013 Feb;6(2):166-8. doi: 10.1016/j.jcin.2012.12.001.

High on-treatment platelet reactivity (HPR): what does it mean, and does it matter?

Thromb Haemost. 2013 Feb;109(2):177-8. doi: 10.1160/TH12-12-0910. Epub 2013 Jan 10.

Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) study.

Thromb Haemost. 2013 Feb;109(2):347-55. doi: 10.1160/TH12-06-0378. Epub 2012 Dec 6.

Switching acute coronary syndrome patients from prasugrel to clopidogrel.

JACC Cardiovasc Interv. 2013 Feb;6(2):158-65. doi: 10.1016/j.jcin.2012.09.012.

Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity.

Int J Cardiol. 2014 Jul 1;174(3):874-6. doi: 10.1016/j.ijcard.2014.04.208. Epub 2014 Apr 26.

Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel Dose versus prasugrel: the RESET GENE trial.

Circ Cardiovasc Interv. 2012 Oct;5(5):698-704. doi: 10.1161/CIRCINTERVENTIONS.112.972463. Epub 2012 Oct 9.

Letter by Alexopoulos et al regarding article, "pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel dose versus prasugrel: the RESET GENE Trial".

Circ Cardiovasc Interv. 2013 Feb;6(1):e11. doi: 10.1161/CIRCINTERVENTIONS.112.975953.

Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy.

Thromb Res. 2013 Jul;132(1):e36-41. doi: 10.1016/j.thromres.2013.05.029. Epub 2013 Jun 19.

Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial.

Thromb Haemost. 2014 Aug;112(2):311-22. doi: 10.1160/TH13-09-0747. Epub 2014 Apr 10.

Prasugrel versus clopidogrel.

N Engl J Med. 2008 Mar 20;358(12):1298-9; author reply 1299-301.

引用本文的文献

Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease.

Eur Heart J Suppl. 2018 May;20(Suppl F):F1-F74. doi: 10.1093/eurheartj/suy019. Epub 2018 May 31.

Switching P2Y12-receptor inhibitors in patients with coronary artery disease.

Nat Rev Cardiol. 2016 Jan;13(1):11-27. doi: 10.1038/nrcardio.2015.113. Epub 2015 Aug 18.

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor.

Eur Heart J Acute Cardiovasc Care. 2015 Dec;4(6):555-60. doi: 10.1177/2048872614554108. Epub 2014 Sep 29.

Platelet function testing in contemporary clinical and interventional practice.

Curr Treat Options Cardiovasc Med. 2014 May;16(5):300. doi: 10.1007/s11936-014-0300-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验